
Please try another search
Chengdu Kanghua Biological Products Co., Ltd. engages in the research, development, production, sale, and technical service of biological products in China. It offers group ACYW135 meningococcal polysaccharide vaccines; and freeze-dried human diploid cell rabies vaccines. The company also develops seasonal influenza vaccines. In addition, it exports its products. The company was founded in 2004 and is based in Chengdu, China.
Name | Age | Since | Title |
---|---|---|---|
Xiongping Yu | - | 2021 | Non-Independent Director |
Zhentao Wang | - | 2021 | Non-Independent Director |
Shuqing Wu | 36 | 2018 | Chairman of the Supervisory Board |
Zhen Tao Wang | 59 | 2018 | Chairman |
Qiangwei Zhang | 36 | 2021 | Supervisor |
Xiaowen Li | 40 | 2021 | Employee Representative Supervisor |
Haiying Tao | 49 | 2021 | Independent Director |
Xiaobo Fang | 51 | 2020 | Independent Director |
Wennian Wu | 42 | 2022 | VP, CFO, Secretary of the Board & Director |
Hongbo Wu | 57 | 2023 | President & Non-Independent Director |
Xiongping Yu | 49 | 2018 | Director |
Guangchang Wang | 44 | 2024 | Independent Director |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review